Division of Hematology and Oncology Archive

April 14, 2026

Genomic testing finds a higher prevalence of high-risk breast cancer in Black women

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.

By Bill Snyder
December 12, 2025

Lucy Spalluto and Jennifer Lewis awarded $1 million lung cancer screening grant

Lung cancer is the leading cause of cancer death in the United States, with incidence higher in veterans compared to the civilian population.

By Derek Scancarelli
(AdobeStock)
October 14, 2025

VUMC researchers awarded $2 million to expand AI-powered medical record abstraction

The grant extension will expand applications in research, clinical trials, registries and national collaborations.

Among those in Washington, D.C., were, from left, Nicholas Warren, Shelagh Mulvaney, PhD, Alvin Powers, MD, Patrick Hu, MD, PhD, Hyun Song, PhD, Ronald McMillan, PhD, and Sara Kavanaugh.
September 25, 2025

Vanderbilt scientists advocate for NIH funding in Congress

Scientists from Vanderbilt University Medical Center and Vanderbilt University joined other advocates from Tennessee to share why continued bipartisan support for NIH is important to them.

By Nicholas Warren
Megan Dupuis, MD, PhD
August 14, 2025

Megan Dupuis named Internal Medicine Residency Program director

Beginning in July 2026, Dupuis will coordinate all aspects of the internal medicine residency, including the interview and selection process, mentoring the residents going through the program.

By Jill Clendening
August 1, 2025

Study reports final clinical trial data for advanced kidney cancer treatment

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.

By Leigh MacMillan